Oaktree Specialty Lending Corp
Business
Oaktree Specialty Lending Corporation is a closed-end, externally managed Business Development Company providing customized credit solutions to middle-market companies. The company invests primarily in first and second lien loans, unitranche loans, mezzanine debt, unsecured loans, and equity co-investments across U.S. middle-market companies. Portfolio investments span 143 portfolio companies with the majority allocated to senior secured loans. The company is externally managed by Oaktree Fund Advisors LLC and operates as a regulated investment company.
Summary from 10-K filed 2025-11-18
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-09-30 | FY 2024 2024-12-31 | FY 2024 2024-09-30 | FY 2023 2023-12-31 | FY 2023 2023-09-30 |
|---|---|---|---|---|---|---|
| Interest on cash and cash equivalents | 5 | — | 6 | — | 4 | |
| Total interest income | 288 | — | 346 | — | 349 | |
| PIK interest income | 19 | — | 21 | — | 20 | |
| Fee income | 6 | — | 9 | — | 7 | |
| Dividend income | 3 | — | 5 | — | 4 | |
| Total investment income | 317 | — | 382 | — | 379 | |
| Base management fee | 30 | — | 43 | — | 45 | |
| Part I incentive fee | 28 | — | 35 | — | 36 | |
| Professional fees | 5 | — | 5 | — | 6 | |
| Directors fees | 640,000 | — | 640,000 | — | 640,000 | |
| Interest expense | 116 | — | 129 | — | 112 | |
| Administrator expense | 2 | — | 2 | — | 1 | |
| General and administrative expenses | 4 | — | 3 | — | 4 | |
| Total expenses | 185 | — | 216 | — | 204 | |
| Management fees waived | −933,000 | — | −5 | — | −6 | |
| Part I incentive fees waived | −20 | — | −4 | — | 0 | |
| Net expenses | 163 | — | 207 | — | 199 | |
| Net investment income before taxes | 154 | — | 175 | — | 181 | |
| (Provision) benefit for taxes on net investment income | −861,000 | — | 0 | — | 0 | |
| Excise tax | 0 | 0 | 0 | −100,000 | −78,000 | |
| Net investment income | 153 | — | 175 | — | 181 | |
| Foreign currency forward contracts | 4 | — | −9 | — | 59,000 | |
| Net unrealized appreciation (depreciation) | −101 | — | 19 | — | −29 | |
| Foreign currency forward contracts | −11 | — | 1 | — | −6 | |
| Net realized gains (losses) | −17 | — | −136 | — | −33 | |
| (Provision) benefit for taxes on realized and unrealized gains (losses) | −394,000 | — | 108,000 | — | −2 | |
| Net realized and unrealized gains (losses), net of taxes | −119 | — | −117 | — | −63 | |
| Net increase (decrease) in net assets resulting from operations | 34 | — | 58 | — | 117 | |
| Net investment income per common share - basic (in dollars per share) | 1.77 | — | 2.18 | — | 2.51 | |
| Net investment income per common share - diluted (in dollars per share) | 1.77 | — | 2.18 | — | 2.51 | |
| Earnings (loss) per common share - basic (in dollars per share) | 0.39 | — | 0.72 | — | 1.63 | |
| Earnings (loss) per common share - diluted (in dollars per share) | 0.39 | — | 0.72 | — | 1.63 | |
| Weighted average common shares outstanding - basic (in shares) | 86 | — | 80 | — | 72 | |
| Weighted average common shares outstanding - diluted (in shares) | 86 | — | 80 | — | 72 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-09-30 | FY 2024 2024-09-30 | FY 2023 2023-09-30 | FY 2022 2022-09-30 | FY 2021 2021-09-30 |
|---|---|---|---|---|---|---|
| Investments at fair value | 2,800 | 3,000 | 2,900 | 2,500 | — | |
| Cash and cash equivalents | 80 | 64 | 136 | 24 | 29 | |
| Restricted cash | 0 | 15 | 9 | 3 | 2 | |
| Interest, dividends and fees receivable | 32 | 39 | 45 | 36 | — | |
| Due from portfolio companies | 3 | 13 | 6 | 22 | — | |
| Receivables from unsettled transactions | 5 | 18 | 55 | 5 | — | |
| Due from broker | 16 | 17 | 54 | 46 | — | |
| Deferred financing costs | 10 | 12 | 13 | 7 | — | |
| Deferred offering costs | 143,000 | 125,000 | 160,000 | 32,000 | — | |
| Gross Amount of Recognized Assets | 9 | 0 | 5 | 7 | — | |
| Other assets | 1 | 775,000 | 2 | 2 | — | |
| Total assets | 3,003 | 3,198 | 3,218 | 2,646 | — | |
| Accounts payable, accrued expenses and other liabilities | 2 | 3 | 3 | 4 | — | |
| Base management fee and incentive fee payable | 13 | 16 | — | — | — | |
| Due to affiliate | 2 | 4 | 4 | 3 | — | |
| Interest payable | 12 | 16 | 16 | 8 | — | |
| Payables from unsettled transactions | 15 | 16 | 11 | 27 | — | |
| Derivative liabilities at fair value | 7 | 17 | 48 | 42 | — | |
| Deferred tax liability | 269,000 | 0 | 5,000 | 0 | — | |
| Credit facilities payable | 545 | 710 | 710 | 700 | — | |
| Unsecured notes payable (net of $6,561 and $4,935 of unamortized financing costs as of September 30, 2025 and September 30, 2024, respectively) | 942 | 929 | 891 | 601 | — | |
| Total liabilities | 1,537 | 1,711 | 1,702 | 1,401 | — | |
| Commitments and contingencies (Note 13) | — | — | — | — | — | |
| Common stock, $0.01 par value per share, 250,000 shares authorized; 88,086 and 82,245 shares issued and outstanding as of September 30, 2025 and September 30, 2024, respectively | 881,000 | 822,000 | 772,000 | 611,000 | — | |
| Additional paid-in-capital | 2,350 | 2,264 | 2,166 | 1,828 | — | |
| Accumulated overdistributed earnings | −885 | −777 | −651 | −583 | — | |
| Total net assets (equivalent to $16.64 and $18.09 per common share as of September 30, 2025 and September 30, 2024, respectively) (Note 11) | 1,466 | 1,488 | 1,516 | 1,246 | 1,313 | |
| Total liabilities and net assets | 3,003 | 3,198 | 3,218 | 2,646 | — |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-09-30 | FY 2024 2024-09-30 | FY 2023 2023-09-30 | FY 2022 2022-09-30 | FY 2021 2021-09-30 |
|---|---|---|---|---|---|---|
| Accretion of original issue discount on investments | −18 | −18 | −22 | −29 | −29 | |
| Accretion of original issue discount on unsecured notes payable | 1 | 1 | 783,000 | 679,000 | 572,000 | |
| Amortization of deferred financing costs | 9 | 5 | 5 | 4 | 4 | |
| Deferred taxes | 300,000 | −5,000 | 2 | −1 | 100,000 | |
| Purchases of investments | −959 | −1,281 | −742 | −702 | −1,120 | |
| Proceeds from the sales and repayments of investments | 1,045 | 1,086 | 912 | 694 | 792 | |
| Cash received in the OSI2 Merger | 0 | 0 | 22 | 0 | 21 | |
| (Increase) decrease in interest, dividends and fees receivable | 7 | 2 | 578,000 | −16 | −8 | |
| (Increase) decrease in due from portfolio companies | 9 | −6 | 16 | −21 | 1 | |
| (Increase) decrease in receivables from unsettled transactions | 13 | 38 | −51 | 3 | 3 | |
| (Increase) decrease in due from broker | 2 | 37 | −9 | −44 | −2 | |
| (Increase) decrease in other assets | −720,000 | 906,000 | 14,000 | 619,000 | −1 | |
| Increase (decrease) in accounts payable, accrued expenses and other liabilities | −2 | −458,000 | −53 | 677,000 | −426,000 | |
| Increase (decrease) in base management fee and incentive fee payable | −3 | −4 | −489,000 | −17 | 20 | |
| Increase (decrease) in due to affiliate | −3 | −222,000 | 408,000 | −1 | 1 | |
| Increase (decrease) in interest payable | −4 | 224,000 | 4 | 3 | 1 | |
| Increase (decrease) in payables from unsettled transactions | −655,000 | 5 | −16 | 19 | 8 | |
| Increase (decrease) in director fees payable | 0 | 0 | −9,000 | 0 | −90,000 | |
| Net cash provided by (used in) operating activities | 228 | 19 | 229 | 22 | −231 | |
| Distributions paid in cash | −148 | −177 | −180 | −115 | −80 | |
| Borrowings under credit facilities | 500 | 255 | 572 | 300 | 505 | |
| Repayments of borrowings under credit facilities | −665 | −255 | −787 | −230 | −530 | |
| Repayments of unsecured notes | −300 | 0 | 0 | — | — | |
| Issuance of unsecured notes | 300 | 0 | 297 | 0 | 349 | |
| Shares issued under the "at the market" offering | 3 | 93 | 1 | 21 | 0 | |
| Repurchases of common stock under dividend reinvestment plan | −11 | −2 | −2 | −2 | −2 | |
| Shares issued in private placement | 100 | 0 | 0 | — | — | |
| Deferred financing costs paid | −8 | −1 | −11 | −334,000 | −9 | |
| Deferred offering costs paid | −43,000 | −117,000 | −235,000 | −215,000 | 0 | |
| Net cash provided by (used in) financing activities | −229 | −87 | −110 | −27 | 224 | |
| Effect of exchange rate changes on foreign currency | 2 | 701,000 | 827,000 | −851,000 | −1 | |
| Net increase (decrease) in cash and cash equivalents and restricted cash | 1 | −67 | 119 | −5 | −7 | |
| Cash paid for interest | 110 | 122 | 98 | 39 | 24 | |
| Issuance of shares of common stock under dividend reinvestment plan | 0 | 6 | 3 | 3 | 2 | |
| Deferred financing costs | 0 | 1 | 442,000 | 0 | — | |
| Deferred offering costs | 0 | 0 | 12,000 | — | — | |
| Issuance of shares in connection with the OSI2 Merger | 0 | 0 | 334 | 0 | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Oaktree Specialty Lending Corp's CIK number?
Oaktree Specialty Lending Corp's SEC CIK number is 0001414932 (1414932). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Oaktree Specialty Lending Corp's SEC filings?
All of Oaktree Specialty Lending Corp's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did Oaktree Specialty Lending Corp last report earnings?
Oaktree Specialty Lending Corp (OCSL) most recently filed an earnings 8-K with the SEC on May 5, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001193125-26-204937). This is Oaktree Specialty Lending Corp's most recent earnings filing of record — not a forecast of its next earnings date.
What is Oaktree Specialty Lending Corp's most recent earnings 8-K?
Oaktree Specialty Lending Corp's latest earnings 8-K (Item 2.02) was filed May 5, 2026 under accession 0001193125-26-204937. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View Oaktree Specialty Lending Corp's latest earnings 8-K →
Look up any company's CIK number →